|
|
 |
EWDTS Board
 |
President
Anya Pierce B.Sc, Dip. Med Tox, MBA - Ireland
anya@iol.ie
Anya Pierce has worked in toxicology for more than 26
years. She is currently Head of Toxicology at Beaumont
Hospital, Dublin. Her unit supplies the national clinical
toxicology service in Ireland as well as workplace drug
testing and a service to addiction centres and coroners.
She was a founder member of the Irish Society of Toxicology
in 1985 and was the Irish representative to the European
Commission expert group on guidelines for the detection
of drugs of abuse, especially in the workplace, and
co-author of the resultant recommendations.
She is founder member of the European Workplace Drug
testing Society (EWDTS) and a member of the Executive
Committee of the International Association of Forensic
Toxicologists (TIAFT) as well as editor of the TIAFT
Bulletin, the quarterly journal of the Association.
She is a member of the committee on emerging trends/new
synthetic drugs of the National Advisory Committee on
Drugs (NACD) and is secretary of the clinical toxicology
committee of the International Association of Therapeutic
Drug Monitoring and Clinical Toxicology (IATDMCT).
|
 |
Past-President
Per Björklöv, Sweden
per.bjorklov@telia.com
Born in Uppsala, Sweden. Studies at University of Stockholm
(teaching, information and marketing) and University
of Uppsala, (Biology and Geography). Started 1991 at
Department of pharmacology at Huddinge university hospital
with the project "workplace drugtesting".
Since 1995 also marketing and information manager for
LabMedicin, which is a laboratory organisation in Stockholm
which perform about 8 million analyses per year and
has about 800 employees. Initiator of the first European
symposium on Drugtesting at Workplace and European Workplace
DrugTesting Society.
|
|
Secretary
Helen Vangikar, United Kingdom
Helen.H.Vangikar@questdiagnostics.com
I graduated from the Institute of Biology, with a Pharmacology
speciality, and fulfilled an ambition of attending the
MSc. in Forensic Science at the University of Strathclyde.
This course, with its heavy technical troubleshooting
basis led me into the field of medical research with the
MRC. I have contributed to a paper on the cancerous effects
of passive exposure to cigarette smoke. After a brief
spell in HIV research, from which I was made redundant,
I spent nearly 13 years at what was known as OmniLabs,
prior to my move to Quest Diagnostics in Nov 2002.
I have spent over 15 years in Workplace Drug and Alcohol
testing field and Quest Diagnostics is the second laboratory
which I have set up and achieved ISO17025 accreditation.
During these 15 years I have been a frequently requested
speaker; Global Safety Conference in Slovenia, October
2002; ISAM 2004 in Finland; BFI 7th 2005 in London. I
have also developed a number of training courses, with
Faculty of Occupational Medicine approval, for occupational
health professionals. In addition I have also been published
in magazines such as Occupational Health, OHS&E and
OH Today.
|
 |
Treasurer
Leendert Mostert, The Netherlands
l.mostert@zhsdirksland.nl
Leendert Mostert holds a M.Sc in Pharmacy obtained in
1984 at the Utrecht University. From 1984 to 1987 he
did his PhD study at department of Clinical Pathology
of the Erasmus Medical Center Rotterdam. In 1989 he
wrote his PhD thesis about "Aspects of iron chelation
and iron release from the liver".
From 1988-1992 he was assistant clinical chemist at
the Department of Clinical Chemistry of the Erasmus
MC in Rotterdam and became board certified clinical
chemist in 1992.
From 1991-2003 he was director of Deltalab one of the
biggest drug testing laboratories in the Netherlands.
Since 2003 he is head of the department of Clinical
Chemistry and Hematology of Van Weel Bethesda Hospital
in Dirksland.
He also has a private collection and drug testing company
Allchemy which performs collections on several sites
in the Netherlands and Belgium.
|
MEMBERS
|
Rolf Breitstadt, Germany
rolf.breitstadt@degussa.com
Born in 1949, Specialist in Internal Medicine and Occupational
health, Employed in the Chemical Industry since more than
20 years, working 17 years for Degussa, an international
active Chemical Company.
Experience in workplace drug testing since 1994, 1996
start with Pre-employment drug testing.
Degussa is aiming to implement drug testing in all activities,
running a drug free workplace policy.
|
|
Cesar Fernandez, Spain
contact@toxscreen.com
Medicine Doctor degree from the University of Zaragoza
(Spain) in 1984. Specialist in the field of Physical Medicine
and Rehabilitation. From 1987 to 1994 Forensic Medicine
Doctor of the Spanish Justice Ministry. Actual Physician
acreditted of the Spanish Sports Superior Council in antidoping
affairs of the Spanish Education, Culture and Sports Ministry.
Actual Vice-President of the Executive Committee of the
Spanish Federation of Sports Medicine. Actual Member of
the Board of the Executive Committee of the European Federation
of Sports Medicine Associations. Actual Member of the
Liaison Commission of the International Federation in
Sports Medicine. Actual Medical Director of Toxscreen
(Drug and Alcohol Testing Service). Actual Head of the
Medico-Legal and Labour Unity of the Institut Universitari
Dexeus (Barcelona).
|
| |
Claire George, United Kingdom
Claire.George@swbh.nhs.uk
Registered Toxicologist, Section Head Drugs of Abuse
The Regional Laboratory for Toxicology, City Hospital,
Birmingham, UK
I have been actively working in the field of illicit
drug monitoring and results interpretation for 8 years.
I am currently the Secretary to the LTG (formally the
London Toxicology Group) and a Council member of the
International Association of Therapeutic Drug Monitoring
and Clinical Toxicology. I have published numerous articles
relating to drugs of abuse testing, specifically the
analysis of the opiate/opioid group of drugs. In addition,
I have given several oral presentations relating to
drugs of abuse testing, including an invited presentation
to the 3rd EWDTS Symposium on Workplace drug testing.
|
|
Lindsay Hadfield, United Kingdom
lindsay.hadfield@Medscreen.com
Policy and Education Consultant
Medscreen Limited, London.
Lindsay has been an EWDTS Board member since 2000 and
has spoken on drug and alcohol testing policy issues
at every EWDTS Symposium. Over the past 16 years with
Medscreen, the UK based specialist workplace drug testing
laboratory with a worldwide client base, she has acquired
a wealth of knowledge and experience from talking to
managers, employees and trade unions, which she uses
to support the introduction and implementation of workplace
drug testing programmes. She edited the final version
of the UK Workplace Drug Testing Guidelines which were
subsequently adopted by the EWDTS.
|
|
John O'Sullivan, Ireland
j.osullivan@claymon.ie
John O'Sullivan has over 13 years experience in Biomedical
Laboratory Sciences - he joined Claymon Laboratories in
1998 as the Section Head of the Biochemistry Dept. (incorporating
Drugs of Abuse Testing laboratory). He has worked extensively
in Hospital Medical Laboratories in both the UK and Ireland.
He holds an M.Sc. in Biomedical Science ( Clinical Chemistry)
and a Fellowship of the Institute of Biomedical Sciences
(FIBMS). He recently obtained the degree of Barrister-at-Law
and was called to the Bar in the Irish Supreme Court in
July 2002.
He is currently Director of Toxicology Services with Claymon
Laboratories and also acts as an advisor with respect
to drugs of abuse testing to both the public and private
sector.
|
|
Leo Rebsdorf, Denmark
rebsdorf@scanscreen.dk
Former positions:
RN SD-Studies at University of Aarhus (Health Education)
Head of Centre for Psychosocial Oncology Treatment
External Lecturer (Health Education)
2 Papers on Psychological Impairment on Coping Strategies
and Immune System of Cancer Patients
Present positions:
Senior Counsellor on Alcohol and Drug Abuse and Policy
Implementation at Workplaces.
Founder and Director of ScanScreen, WDT Company in Denmark
|
|
Alain Verstraete, Belgium
Webmaster
alain.verstraete@ugent.be
Alain Verstraete, MD, specialist in Clinical Biology
and in vitro Nuclear Medicine, is responsible for the
Emergency Laboratory and the Toxicology Laboratory of
Ghent University Hospital. He is part-time professor
at Ghent University.
He is the author of 52 papers in peer-reviewed journals
and gave 110 presentations at international scientific
meetings.
He is president of the Belgian Society of Clinical Biology,
vice-president of the Toxicological Society of Belgium
and Luxembourg and webmaster of the International Association
for Therapeutic drug monitoring and clinical toxicology
(IATDMCT).
He received an 2002 AACC outstanding speaker award,
the 2002 ICADTS (International council on Alcohol, Drugs
and Traffic Safety) Haddon award given to scientists
who take research findings and make changes in public
policy and the 2002 TIAFT achievement award.
He is member of the editorial board of Journal of Analytical
Toxicology, Traffic injury prevention and Acta Clinica
Belgica and deputy editor-in-chief of Annales de Toxicologie
Analytique.
|
|
Majda Zorec-Karlovsek, Slovenia
majda.zorec-karlovsek@mf.uni-lj.si
Dr. Majda Zorec Karlovsek received a bachelor's degree
and in a master's degree in chemistry and a doctoral degree
in forensic medicine from the University of Ljubljana.
She is Assistant Professor for forensic medicine - forensic
toxicology at the Institute for Forensic medicine, Medical
Faculty, University of Ljubljana. Her main research interest
is in alcohol, drugs and driving, prevention of intoxications
and post-mortem biochemistry. She is an Expert for the
Court for Chemistry, Forensic Toxicology and Alcoholometry.
She is a member of several international and national
scientific societies including TIAFT, ICADTS, GDCh and
vice-president of Toxicological Society of Slovenia.
|
|
